Silicon Therapeutics
Boston
About Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company. Their multi-disciplinary team is advancing a paradigm shift in biotechnology by pioneering a physics-driven approach to drug design that is tightly coupled to chemistry and biology R&D. Their unique platform is purpose-built to develop novel small molecule therapeutics to address biologically and genetically validated, but previously intractable, protein targets.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $6.2M
- Funding stage: M&A
- Last round: Series Unknown (Oct 2016)
- Website: silicontx.com
- Phone: (617)937-2300
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/silicon-therapeutics-103073 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.